Biotech: Biologics and cell therapy products

3P Biopharmaceuticals has the GMP (Good Manufacturing Practices) certification issued by the AEMPS for the manufacture and release of biological active substances, the release of biological drugs and the release of sterile products for both human and veterinary use and for the manufacture and release of cell therapy product: human allogeneic adult stem cells extracted from hearth tissue an "in vitro“ expanded.

News

­

October 2017

European Antibody Congress

October 6th, 2017|

Join us at the largest antibody event focused on getting important new therapeutics and immunotherapies into the clinic and see where antibody development is headed next.

The European Antibody Congress is where pharma, biotechs, clinicians, researchers & innovative start-ups gather to develop new strategies and partnerships to advance antibody drug discovery, development, and commercialisation.

When: 31 October […]

September 2017

BIO EUROPE 2017

September 28th, 2017|

 

 

 

 

 

One more year, 3P Biopharmaceuticals is sponsoring the biggest biotech event in Europe: BIO EUROPE 2017.

Meet us at booth 105!

Soon +info!

 

BIO JAPAN 2017

September 28th, 2017|

 

 

 

 

 

BIO JAPAN is Asia’s Premier Partnering Event for the Global Biotechnology Industry.

With over 8,000 meetings expected to take place, this year’s Partnering is set to be our largest and most successful ever!

The Partnering system is entirely shared between BioJapan and Regenerative Medicine Japan, so participants can now reach an even wider range of potential partners […]

CPhI 2017

September 28th, 2017|

The world’s leading pharmaceutical platform

CPhI Worldwide 2017, together with co-located events ICSE, InnoPack, P-MEC and FDF, hosts more than 42,000 visiting pharma professionals over three days. 2,500+ exhibitors from 153 countries gather at the event to network and take advantage of more than 150 free industry seminars. Every sector of the pharmaceutical market is represented under one roof, this year in Frankfurt. Attending CPhI […]

Expoquimia

September 28th, 2017|

Dámaso Molero, General Manager at 3P Biopharmaceuticals, will be presenting at very next edition of Expoquimia.
5 October 10:00 – 11:30
Session 3 –Health and Industrial Biotechnology
Chair:
Teresa Pellicer, Head of BIotechnology Projects, Interquim
Speakers:
Marta Pascual, Scientific Director, Plasmia Biotech
Dámaso Molero, CEO, 3P Biopharmaceuticals
Luis Gosalbez, Business Development Director, Optibiotix

About Expoquimia 2017:
Expoquimia is a unique chemistry exhibition which takes place […]